Eileen Banaga

Vp, Regulatory Affairs And Quality at Sentynl Therapeutics, Inc.

Eileen Banaga currently serves as the Vice President of Regulatory Affairs and Quality at Sentynl Therapeutics, Inc., a position held since April 2016. In this role, Eileen develops and executes global regulatory strategies, leads regulatory affairs activities for commercial products, and manages quality activities related to manufacturing and testing. Prior experience includes positions such as Senior Director and Director of Regulatory Affairs and Quality at AREVA Med LLC, Director of Quality and Regulatory Affairs at Pain Therapeutics, and Quality and Regulatory Affairs Manager for other organizations. Eileen's educational background includes a Master's degree in Regulatory Affairs from San Diego State University and a Bachelor of Science in Medical Technology from St. Louis University.

Location

San Diego, United States

Links


Org chart

No direct reports

Teams


Offices


Sentynl Therapeutics, Inc.

Sentynl Therapeutics, a wholly owned subsidiary of Zydus Lifesciences Ltd., is a commercial stage biopharmaceutical company focused on bringing innovative therapies to patients living with rare diseases.